36
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Prolonged Paralysis After Neuromuscular Blockade

Pages 419-426 | Published online: 25 Sep 2008

References

  • Hansen‐Flaschen J. H., Brazinsky S., Basile C., Lanken P. N. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA 1991; 266: 2870–2875
  • Klessig H. T., Geiger H. J., Murray M. J., Coursin D. B. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992; 20: 1341–1345
  • Roizen M. F., Feeley T. W. Pancuronium bromide. Ann Intern Med 1978; 88: 64–68
  • Barohn R. J., Jackson C. E., Rogers S. J., Ridings L. W., McVex A. L. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17: 647–654
  • Benzing G., Iannaccone S. T., Bove K. E., et al. Prolonged myasthenic syndrome after one week of muscle relaxants. Pediatr Neurol 1990; 6: 190–196
  • Danon M. J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14: 1131–1139
  • Douglass J. A., Tuxen D. V., Home K., et al. Myopathy in severe asthma. Rev Respir Dis 1992; 146: 517–519
  • Gooch J. L., Moore M. E., Ryser D. K. Prolonged paralysis after neuromuscular junction blockade: Case reports and electrodiagnostic findings. Arch Phys Med Rehabil 1993; 74: 1007–1011
  • Gooch J. L., Suchyta M. R., Balbierz J. M., Petajan J. H., Clemmer T. P. Prolonged paralysis after treatment with neuromuscular junction blocking drugs. Crit Care Med 1991; 19: 1125–1131
  • Griffin D., Fairman N., Coursin D., Rawsthorne L., Grossman J. E. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992; 102: 510–514
  • Hirano M., Ott B. R., Raps E. C., et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42: 2082–2087
  • Kupfer Y., Namba T., Kaldawi E., Tessler S. Prolonged weakness after long‐term infusion of vecuronium bromide. Ann Intern Med 1992; 117: 484–486
  • Kupfer Y., Okren D. G., Twersky R. A., Tessler S. Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade. Crit Care Med 1987; 15: 795–796
  • Lacomis D., Smith T. W., Chad D. A. Acute myopathy and neuropathy in status asthmatics. Case report and literature review. Muscle Nerve 1993; 16: 84–90
  • Op de Coul A. A., Lambregts P. C., Koeman J., Van Puyenbroek M. J., Ter Laak H. J., Gabreels‐Festen A. A. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985; 87: 17–22
  • Partridge B. L., Abrams J. H., Bazemore C., Rubin R. Prolonged neuromuscular blockade after long‐term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990; 18: 1177–1179
  • Ramsay D. A., Zochodne D. W., Robertson D. K., Nag S., Ludwin S. K. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52: 387–398
  • Rossiter A., Souney P. F., McGowan S., Carvajal P. Pancuronium‐induced prolonged neuromuscular blockade. Crit Care Med 1991; 19: 1583–1587
  • Segredo V., Caldwell J. E., Matthay M. A., Sharma M. L., Gruenke L. D., Miller R. D. Persistent paralysis in critically ill patients after long‐term administration of vecuronium. N EnglJ Med 1992; 327: 524–528
  • Sitwell L. D., Weinshenker B. G., Monpetit V., Reid D. Complete ophthalmoplegia as a complication of acute corticosteroid and pancuronium associated myopathy. Neurology 1991; 41: 921–922
  • Subramony S. H., Carpenter D. E., Raju S., Pride M., Evans O B. Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991; 19: 1580–1582
  • Torres C. F., Maniscalco W. M. Muscle weakness and atrophy following prolonged paralysis with pancuronium bromide in neonates. Ann Neurol 1995; 18: 403
  • Vanderheyden B. A., Reynolds H. N., Gerold K. B., Emanuele T. Prolonged paralysis after long‐term vecuronium infusion. Crit Care Med 1992; 201: 304–307
  • Wokke J. H., Jennekens F. G., van den Oord C. J., VeJdman H., van Gijn J. Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness. J Neurol Sci 1988; 88: 95–106
  • Zochodne D. W., Ramsay D. A., Shelley S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994; 17: 285–292
  • Shanks A. B., Long T., Aitkenhead A. R. Prolonged neuromuscular blockade following vecuronium. Br J Anaesth 1985; 57: 807
  • Belafsky M. A., Klawans H. L. Prolonged neuromuscular blockade with pancuronium bromide in a young healthy woman. Anesthesiology 1974; 40: 295–296
  • Kaplan P. W., Rocha W., Sanders D. B., D'Souza B., Spock A. Acute steroid‐induced tetraplegia following status asthmaticus. Pediatrics 1986; 78: 121–123
  • Miller R. D., Rupp S. M., Fisher D. M., Cronnelly R., Fahey M. R., Sohn Y. J. Clinical pharmacology of vecuronium and atracurium. Anesthesiology 1984; 61: 444–453
  • Rouleau G., Karpati G., Carpenter S., Soza M., Prescott S., Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987; 10: 428–438
  • Massa R., Carpenter S., Holland P., Karpati G. Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervation. Muscle Nerve 1992; 15: 1290–1298
  • DuBois D. C., Almon R. R. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981; 4: 370–373
  • Feldman S. A. Effect of changes in electrolytes, hydration and pH upon the reactions to muscle relaxants. Br J Anaesth 1963; 35: 546
  • Witt N. J., Bolton C. F., Sibbald W. J. The incidence and early features of the polyneuropathy of critical illness. Neurology 1985; 35(Supplement 1)74
  • Bolton C. F., Gilbert J. J., Hahn A. F., Sibbald W. J. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47: 1223–1231
  • Zochodne D. W., Bolton C. F., Wells G. A., Gilbert J. J., Hahn A. F., Brown J. D., Sibbald W. A. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110: 819–841
  • Pribble C., Timmons O., Moore M., Gooch J. Risk factors for prolonged weakness after vecuronium infusions in pediatric patients. Crit Care Med 1995, In press
  • Krendel D. A., Reid C., Roeske L. Persistent weakness following atracurium and corticosteroid administration. Muscle Nerve 1994; 17: 1124
  • Hansen‐Flaschen J., Cowen J., Raps E. C. Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993; 147: 234–236

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.